Head-to-head · WeighScore
Bioverse vs Fierce Health
The verdict
Bioverse takes it — 65.2/100 to 56.6/100.
Bioverse grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bioverse | Fierce Health |
|---|---|---|
| WeighScore | 65.2/100 | 56.6/100 |
| Grade | C | C |
| Scorecard rank | #224 | #410 |
| Semaglutide | $129/mo (starting dose, compounded) | $297/mo (3-month plan, compounded) |
| Tirzepatide | $399/mo (starting dose, compounded) | $497/mo (3-month plan, compounded) |
| Coverage | Coverage not published | 30 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #224 · C
Strengths
- Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
- No membership, cancellation, doctor, or hidden fees
- Uses US-licensed, FDA-regulated pharmacies
Where it loses points
- No visible LegitScript or PCAB accreditation
- State availability not disclosed beyond 'a provider licensed in your state'
- Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
Graded #410 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.